CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, announced that its Annual Report on Form 10-K for the fiscal year ended December ...

Sanuj Bhatia is a Features and News writer for Pocket-lint, specializing in smartphones and wearables. He also keeps a keen eye on smart home gadgets, TVs, and everything in the Apple ecosystem.

The share price of CVR Energy, Inc. (NYSE:CVI) fell by 8.47% between February 11 and February 18, 2026, putting it among the Energy Stocks that Lost the Most This Week. CVR Energy, Inc. (NYSE:CVI) is ...

Headquartered in Sugar Land, Texas, CVR Partners, LP is a Delaware limited partnership focused on the production, marketing and distribution of nitrogen fertilizer products. It primarily produces urea ...

Company AnnouncementCOPENHAGEN, Denmark; March 19, 2026 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on March 19, 2026, the Company’s Board of Directors met to ...

SUGAR LAND, Texas--(BUSINESS WIRE)-- CVR Partners, LP (UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, announced that its Annual Report on Form 10-K for ...

Mark Pytosh, CEO, opened with the introduction of a new Chief Operating Officer, Mike Wright, emphasizing his 35 years of industry experience and his dual role as COO of CVR Energy since January 2022.

LONDON — The global fallout from the Epstein files widened Wednesday, with French authorities urging survivors to come forward and British police assessing private flights to and from London connected ...

Blockchain technology experts in Nigeria say the country could improve trust in its elections by using blockchain systems to secure ...

Amount represents the cumulative available cash for distribution based on full-year results. However, available cash for distribution is calculated quarterly, with distributions (if any) being paid in ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.